Alzheimer's drug shows long-term benefits in behavior and cognition. EU approval of Blarcamesine could boost its market value ...

Q1 2025 Results Conference Call May 15, 2025 5:00 AM ETCompany ParticipantsEric Lindquist - Managing Director and ...

Tracking stock prices from their 52-week lows can can help investors spot potential buying opportunities. Here’s how to do ...

Oklo's Small Modular Reactors are offering potential solutions to AI's growing energy demands. Read more to know if OKLO is ...

Can prescription benefit managers, or PBMs, be eliminated from the U.S. drug pricing process? Seeking Alpha analysts weigh in. Read more here.

Q2 2025 Results Conference Call May 15, 2025 10:00 AM ETCompany ParticipantsJosh Beal - Director of Investor RelationsJohn ...

Welcome to Hafnia's First Quarter 2025 Financial Results Presentation. We will begin shortly. You will be brought through today's presentation by Hafnia's CEO, Mikael Skov; CFO, Perry Van Echtelt; VP ...

Avadel Pharmaceuticals is gaining momentum with strong Q1 results, a key legal win, and moving swiftly to profitability. Read ...

Investor sentiment appears increasingly divided as questions loom over the future direction of Wall Street. While markets ...

America faces a four-pronged credit crunch: commercial real estate, corporate, consumer, and government debt all peaking ...

Paycom shines in the SaaS HCM space with 20% annual sales growth, strong margins, and client retention. Discover why it's a ...

Janus Henderson AAA CLO ETF, investing primarily in CLOs, targets senior and junior CLOs that are mostly triple-A rated.